(PRWEB) September 13, 2014

The “Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) – Global Forecast to 2018” report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global cell culture market along with the estimates and forecasts of the revenue and market share analysis.

Browse 91 market data tables and 19 figures spread through 209 Pages and in-depth TOC on”Cell Culture Market”

http://www.marketsandmarkets.com/Market-Reports/cell-culture-market-media-sera-reagents-559.html

Early buyers will receive 10% customization on this report.

The global cell culture market was valued at an estimated $ 14,772 million in 2013. This market is expected to grow at a CAGR of 10.71% between 2013 and 2018, to reach $ 24,574 million in 2018.

Ask for PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=559

Cell culture has its applications in a large number of fields including biopharmaceutical production, drug screening and development, gene therapy, toxicity testing, and life science research. It is one of the most widely used techniques for biopharmaceutical and vaccine production. According to IMS Health, biologics (which includes biopharmaceuticals and vaccines) are expected to grow at a CAGR of about 18% by 2017. The rapid growth in biopharmaceutical and vaccine production will be the primary driver for the cell culture market between 2013 and 2018. Furthermore, increase in the healthcare spending and increased R&D activities will aid the growth of this market.

Cell culture is the most widely used techniques for biopharmaceutical production and has its applications in drug screening and development, gene therapy, toxicity testing, and cancer research. Rapid growth in the biopharmaceutical market, increase in the healthcare spending, and increased R&D activities will drive the growth of the global cell culture market.

The global cell culture market is a highly evolved market. There is a high degree of consolidation in this market. An analysis of the market developments between 2011 and 2014 reveals that new product launches was the most important growth strategy employed by market leaders in this period. This strategy was adopted by all players in this market, except Lonza (Switzerland). Lonza was the only company among all the market leaders that did not launch any new products between 2011 and 2014.

For More Inquiry Speak to Analyst @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=559

The cell culture media, sera, and reagents market consists of six segments, namely, contamination detection kits, cryoprotective agents, lab reagents, media, serum, and other reagents. Of these, the serum product segment had the largest share of the cell culture media, sera, and reagents market in 2013, whereas the media product segment is expected to grow at the highest CAGR between 2013 and 2018. The subsegments of the lab reagents segment are balanced salt solutions, buffers and chemicals, cell dissociation reagents, and supplements and growth factors. The subsegments of the media segment are basal media, reduced serum media, and serum-free media.

The application segments included in this report are biopharmaceutical production, cancer research, drug screening and development, gene therapy, tissue culture and engineering, toxicity testing, vaccine production, and other applications. The biopharmaceutical production application segment had the largest share of the cell culture equipment market in 2013, whereas the vaccine production application segment is expected to grow at the highest CAGR between 2013 and 2018. The geographic segments included in this report are North America, Europe, Asia-Pacific, and Rest of the World.

Biopharmaceuticals are pharmaceutical products isolated from living systems like cells. As such, cell culture is the most widely used technique for biopharmaceutical production. Increasing demand for biopharmaceuticals will be the most important growth driver for the cell culture market. Furthermore, strong product pipelines for vaccine and antibodies, increasing healthcare expenditure, and increasing adoption of single-use technologies will aid the growth of this market.

The major players in the cell culture market include Becton, Dickinson and Company (U.S.), Corning (U.S.), Eppendorf (Germany), General Electric (U.S.), Lonza (Switzerland), Merck (Germany), Promocell (Germany), Sartorius (Germany), Sigma-Aldrich Corporation (U.S.), and Thermo Fisher Scientific (U.S.).

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:

Mr. Rohan

North – Dominion Plaza

17304 Preston Road

Suite 800, Dallas, TX 75252

Tel: +1-888-600-6441

Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/pharmaceuticals

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets






Find More Technology Press Releases

Tags